Best in 7 days FDA considers adding a dozen peptides to its bulk drug compounding list US$ 27.47 Sold : Login>>
Best in 7 days In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC-157 and Melanotan II. The move comes as demand for “ US$ 23.50 Sold : Login>>
Best in 7 days BPC 157 FDA Approval Unlikely Due to Patent Economics | Stefano M. Sinicropi, MD posted on the topic US$ 22.80 Sold : Login>>
Dihexa UK — The UK's Leading Dihexa Peptide Resource US$ 26.11 Min. order: 1 piece ★★★★★ 4.2 (191 reviews) Sold : Login>>
10 clinical trials to watch in the first half of 2026 US$ 22.55 Min. order: 1 piece ★★★★★ 4.7 (294 reviews) Sold : Login>>
Clinical Research in 2026:What's Changing and Why It Matters US$ 22.10 Min. order: 1 piece ★★★★★ 4.6 (99 reviews) Sold : Login>>
Dihexa Peptide Therapy | Memory & Cognition US$ 25.41 Min. order: 1 piece ★★★★★ 4.0 (293 reviews) Sold : Login>>